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Department of Hepatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DenmarkIn acute liver failure, liver transplantation performed within a
time frame of hours to a few days may radically improve the out-
come. In patients with an etiology of acute viral, toxic, autoim-
mune, or cryptogenic hepatitis, the procedure may indeed be
life saving. However, the patients with the most dramatic clinical
presentation, paracetamol-induced hyperacute liver failure,
remain the only group that have a high spontaneous survival rate,
even though they may experience advanced stages of disease
with multi-organ failure and brain oedema. The selection criteria
for emergency liver transplantation in patients with paraceta-
mol-induced liver failure are far from optimal, and there clearly
remains a need for improving the selection criteria for transplan-
tation in this group of patients.
Lactate has been used as a marker of poor prognosis in
patients with a variety of critical conditions requiring intensive
care management. In general, the measurement of lactate con-
centration in a mixed cohort of patients with acute liver failure
has turned out to be of limited value for decision making in daily
practice. However, patients with paracetamol-induced hyper-
acute liver failure often present with severe lactate acidosis that
frequently is associated with cardiovascular collapse and immi-
nent death. In this subgroup of patients with acute liver failure,
lactate could be of potential value as a prognostic marker.
Among several selection criteria for urgent liver transplanta-
tion, the King’s College Hospital (KCH) criteria have proven
robust and gained considerable acceptance [1]. The KCH criteria
are recognised as being quite speciﬁc, but at the cost of limited
sensitivity. Furthermore, patients frequently fulﬁll the criteria
at a progressed stage of liver failure, where the severity of the
clinical condition may contraindicate liver transplantation. Con-
sequently, it is of interest to identify prognostic markers that
improve the sensitivity and allow for earlier identiﬁcation of
transplant candidates.
In 2002, Bernal et al. suggested that addition of early lactate
measurement to the KCH criteria improved both their sensitivity
and the speed of identiﬁcation of transplantation candidates [2].
In patients with paracetamol-induced liver failure, hyperlactata-
emia reﬂects not only alterations in systemic haemodynamics
and oxygen utilization, but more importantly, a severity of liver
injury from which the patient is unlikely to spontaneouslyJournal of Hepatology 20
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Open access under CC BY-NC-ND license.recover. Lactate has many of the prerequisites of a useful prog-
nostic test: gathering of arterial blood samples are routine in
the Intensive Care Unit, and analysis can be performed immedi-
ately at bedside. Interpretation of the results, as deﬁned by Bernal
et al., is straightforward, and the test was proposed to provide
information not available from established tests. However, a seri-
ous concern about lactate as a prognostic marker was whether
the experiences from KCH could be extrapolated to other liver
centres [3].
Though subsequent studies consistently found a signiﬁcant
association between arterial lactate and survival from paraceta-
mol-induced acute liver failure, the prognostic value was gener-
ally poorer, mainly due to low speciﬁcity [4–9]. In one report
from a centre with low transplantation activity, the majority of
patients fulﬁlling the lactate criteria were observed to survive
without liver transplantation [9]. This is particularly unfortunate
if lactate is applied as an early indicator of poor prognosis leading
to early liver transplantation; however, at a centre with a high
transplant activity and rapid access to donor organs the potential
spontaneous survivability of hyperlactataemia may well go
unrecognized. Nevertheless, persistently elevated blood lactate
levels despite adequate ﬂuid resuscitation appear strongly indic-
ative of a poor prognosis [4].
The liver intensive care unit at KCH is very specialized, and
patients transferred are highly selected, illustrated by the strict
criteria for transferral and the relatively high mortality. Thus,
the large majority of patients admitted to KCH for severe para-
cetamol overdose most often present with or progress into
acute liver failure, and a large proportion will be considered
for emergency liver transplantation. At other liver centres
including our own national liver failure unit, patients with
severe paracetamol-induced liver injury are transferred earlier,
fewer have grade 3 or 4 hepatic encephalopathy at initial pre-
sentation, and fewer patients end up being transplanted [6,9].
The lower rate of transplantation may reﬂect a lower availabil-
ity of organs, a higher proportion of patients with contraindica-
tions to liver transplantation, and the fact that a number of
patients are allowed to spontaneously recover, who would per-
haps have been transplanted early at centres with easier access
to organs [9].
Overall, it is clear that lactate lacks the speciﬁcity required to
be a sole criterion for listing for emergency liver transplantation
in patients with acute liver failure. Furthermore, the addition of
lactate to the KCH criteria appears to offer no major advantages
over the existing criteria [4,6,8,9] and there still a need for opti-
mizing the selection criteria for these critically ill patients.10 vol. 53 j 211–212
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